952
Views
54
CrossRef citations to date
0
Altmetric
Brief Report

Late development of splenic sarcoidosis-like lesions in a patient with metastatic melanoma and long-lasting clinical response to ipilimumab

, , &
Article: e954506 | Received 27 May 2014, Accepted 18 Jul 2014, Published online: 29 Oct 2014

References

  • Hodi F, O’Day S, McDermott D, Weber R, Sosman J, Haanen J, Gonzalez R, Roberts C, Schadendorf D, Hassel J, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363:711-23; PMID:20525992; http://dx.doi.org/10.1056/NEJMoa1003466
  • Prieto PA, Yang JC, Sherry RM, Hughes MS, Kammula US, White DE, Levy CL, Rosenberg SA, Phan GQ. CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma. Clin Cancer Res 2012; 18:2039-47; PMID:22271879; http://dx.doi.org/10.1158/1078-0432.CCR-11-1823
  • Eckert A, Schoeffler A, Dalle S, Phan A, Kiakouama L, Thomas L. Anti-CTLA4 monoclonal antibody induced sarcoidosis in a metastatic melanoma patient. Dermatology 2009; 218:69-70; PMID:18832811; http://dx.doi.org/10.1159/000161122
  • Berthod G, Lazor R, Letovanec I, Romano E, Noirez L, Stalder J, Speiser D, Peters S, Michielin O. Pulmonary sarcoid-like granulomatosis induced by ipilimumab. J Clin Oncol 2012; 30:10-3; PMID:22547608; http://dx.doi.org/10.1200/JCO.2011.39.3298
  • Vogel W, Guislain A, Kvistborg P, Schumacher T, Haanen J, Blank C. Ipilimumab-induced sarcoidosis in a patient with metastatic melanoma undergoing complete remission. J Clin Oncol 2012; 30:7-10; PMID:22124098; http://dx.doi.org/10.1200/JCO.2011.37.9693
  • Wilgenhof S, Morlion V, Seghers AC, Du Four S, Vanderlinden E, Hanon S, Vandenbroucke F, Everaert H, Neyns B. Sarcoidosis in a patient with metastatic melanoma sequentially treated with anti-CTLA-4 monoclonal antibody and selective BRAF inhibitor. Anticancer Res 2012; 32:1355-9; PMID:22493370
  • Reule RB, North JP. Cutaneous and pulmonary sarcoidosis-like reaction associated with ipilimumab. J Am Acad Dermatol 2013; 69:e272-3; PMID:24124863; http://dx.doi.org/10.1016/j.jaad.2013.07.028
  • Tissot C, Carsin A, Freymond N, Pacheco Y, Devouassoux G. Sarcoidosis complicating anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody biotherapy. Eur Respir J 2013; 41:246-7; PMID:23277525; http://dx.doi.org/10.1183/090319-36.00107912
  • Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 2003; 361:1111-8; PMID:12672326; http://dx.doi.org/10.1016/S0140-6736(03)12888-7
  • Iannuzzi M, Fontana J. Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics. Jama 2011; 305:391-9; PMID:21266686; http://dx.doi.org/10.1001/jama.2011.10
  • Rosen Y. Pathology of sarcoidosis. Semin Respir Crit Care Med 2007; 28:36-52; PMID:17330191; http://dx.doi.org/10.1055/s-2007-970332
  • Seve P, Schott AM, Pavic M, Broussolle C, Gilis L, Thomas L. Sarcoidosis and melanoma: a referral center study of 1,199 cases. Dermatology 2009; 219:25-31; PMID:19365109; http://dx.doi.org/10.1159/000213245
  • Zia H, Zemon H, Brody F. Laparoscopic splenectomy for isolated sarcoidosis of the spleen. J Laparoendosc Adv Surg Tech 2005; 15:160-2; PMID:15898908; http://dx.doi.org/10.1089/lap.2005.15.160
  • Chen M-Y, Cai J-T, Du Q, Wang L-J. Sarcoidosis of spleen presenting with solitary thrombopenia. Eur J Intern Med 2009; 20:e12; PMID:19237065; http://dx.doi.org/10.1016/j.ejim.2007.09.022
  • Mohan A, Sood R, Shariff N, Gulati MS, Gupta SD, Dutta AK. Sarcoidosis manifesting as massive splenomegaly: a rare occurrence. Am J Med Sci 2004; 328:170-2; PMID:15367876; http://dx.doi.org/10.1097/00000441-200409000-00007

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.